Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ALNY - Alnylam Pharmaceuticals, Inc.
-336 M
LAST VALUE
-10.94%
2 YEAR CAGR
-17.42%
5 YEAR CAGR
-9.93%
10 YEAR CAGR